MARC보기
LDR00000nam u2200205 4500
001000000435246
00520200227165217
008200131s2014 ||||||||||||||||| ||eng d
020 ▼a 9781687976970
035 ▼a (MiAaPQ)AAI27603088
035 ▼a (MiAaPQ)OhioLINKosu1397560686
040 ▼a MiAaPQ ▼c MiAaPQ ▼d 247004
0820 ▼a 614
1001 ▼a Hsu, En-Chi.
24510 ▼a Targeting ILK to Eliminate IL-6 Induced Cancer Stem Cell Phenotype.
260 ▼a [S.l.]: ▼b The Ohio State University., ▼c 2014.
260 1 ▼a Ann Arbor: ▼b ProQuest Dissertations & Theses, ▼c 2014.
300 ▼a 138 p.
500 ▼a Source: Dissertations Abstracts International, Volume: 81-06, Section: B.
500 ▼a Advisor: Chen, Ching-Shih.
5021 ▼a Thesis (Ph.D.)--The Ohio State University, 2014.
506 ▼a This item must not be sold to any third party vendors.
520 ▼a Cancer stem cell (CSC) has been associated with the aggressive phenotype of cancer, including potent cancer initiation, drug resistance and metastasis. Triple negative breast cancer (TNBC), a breast cancer subtype with aggressive behavior and no effective targeting therapy, has been shown correlations with autocrine interleukin-6 (IL-6) dependent survival and increasing CSC population. The inflammatory cytokine IL-6 induces CSC by activating STAT3 and NF-觀B pathway. Integrin-linked kinase (ILK), which links cell-adhesion receptors, integrins and growth factors to the actin cytoskeleton and regulates multiple signaling pathways such as Akt, AP-1 and NF-觀B pathways, is highly expressed in various cancers. In breast cancer cell lines, we showed that ILK expression is tightly associated with IL-6 expression and Notch1 activation, which is important for maintaining the self-renewal capacity of CSC. The objective of this study is to characterize the regulatory interactions among IL-6, ILK, and Notch1 in breast CSC. Our work shows that IL-6 upregulated ILK expression via E2F1 which, in turn, amplified the IL-6-NF-觀B positive signaling loop and stimulated downstream Notch1 activation. We also identified a novel role for ILK in the maturation of gamma-secretase, which cleaves and activates Notch 1. Immunohistochemical staining of a human breast tumor tissue microarray revealed a positive correlation between ILK and IL-6 expression. Moreover, high ILK expression showed low relapse-free survival probability (P = 0.045) among subgroup of patients with high IL-6 expression. These data indicate an integral role of ILK in IL-6-mediated signaling and consequent induction in CSC
590 ▼a School code: 0168.
650 4 ▼a Biochemistry.
650 4 ▼a Biomedical engineering.
650 4 ▼a Molecular biology.
650 4 ▼a Pharmaceutical sciences.
650 4 ▼a Physiology.
650 4 ▼a Epidemiology.
650 4 ▼a Public health.
650 4 ▼a Oncology.
650 4 ▼a Health sciences.
690 ▼a 0487
690 ▼a 0572
690 ▼a 0541
690 ▼a 0307
690 ▼a 0573
690 ▼a 0566
690 ▼a 0992
690 ▼a 0766
690 ▼a 0719
71020 ▼a The Ohio State University. ▼b Pharmacy.
7730 ▼t Dissertations Abstracts International ▼g 81-06B.
773 ▼t Dissertation Abstract International
790 ▼a 0168
791 ▼a Ph.D.
792 ▼a 2014
793 ▼a English
85640 ▼u http://www.riss.kr/pdu/ddodLink.do?id=T15494585 ▼n KERIS ▼z 이 자료의 원문은 한국교육학술정보원에서 제공합니다.
980 ▼a 202002 ▼f 2020
990 ▼a ***1008102
991 ▼a E-BOOK